Ads
related to: keytruda cancer drug- Contact Us
Have Questions? Don’t Hesitate.
Contact Us Today.
- Precision Oncology
Finding Cancer's Fingerprint.
Learn More.
- NRG1 Fusion
More Aggressive Than You Think.
Learn About NGR1 Today.
- Genomic Landscape
Genomics are Changing the Future
of Oncology. Learn More.
- Contact Us
Search results
Gene-Targeted Immunotherapy Boosts Survival for Some Colon Cancer Patients
KPVI· 3 days agoDoctors in Britain say that an immunotherapy drug, given before surgery, can help many more patients...
Drug already available on NHS could help cure deadly form of bowel cancer
Daily Telegraph· 3 days agoPembrolizumab works by blocking the action of a molecule called PD-1 that hides the cancer from the...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
NBC New York· 3 days agoModerna and Merck said their experimental vaccine in combination with the therapy Keytruda improved survival and showed durable efficacy in a midstage study in patients with ...
‘I can’t explain why’: Does this dog dewormer cure cancer? These Facebook groups say yes
The Daily Dot· 6 days agoThree months later, the cancer had grown. From a cattle farm in Louisiana where she’s helping a...
Merck, Moderna Drug Combo Shows Improved Survival in Skin Cancer Trial
Morningstar· 3 days agoModerna and Merck said they saw positive results from a Phase 2b study evaluating mRNA-4157 in combination with Keytruda in patients with high-risk skin cancer< ...
Lack of Insurance Keeps Many Americans From Best Cancer Meds
US News & World Report· 3 days agoNew policies are needed "to improve health insurance coverage options and to make new treatments more affordable," the American Cancer Society (ACS) said in a news release ...
Experimental Therapy Shows Promise in Pancreatic C | Newswise
Newswise· 7 days agoImmunotherapy drugs alone have not shown to be responsive to pancreatic cancer. The findings were presented at the American Society of Clinical Oncology 2024 annual meeting ...
Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors...
The Woonsocket Call· 5 days agoOlomorasib is an investigational, oral, potent, and highly selective second-generation inhibitor of the KRAS G12C protein.
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Reuters via Yahoo News· 3 days agoDetailed data on Monday from the 157-patient trial showed that after two and a half years, melanoma...
Gene-Targeted Immunotherapy Boosts Survival for Some Colon Cancer Patients
US News & World Report· 3 days agoDoctors in Britain say that an immunotherapy drug, given before surgery, can help many more patients with a specific genetic profile stay cancer-free long ...